text: <html>
          <head> <meta charset="UTF-8">
          <style>
          table, th, td {
              border: 1px solid black;
              font-size: 10px;
          }
          </style> </head>
          <body>
          <table frame="hsides" rules="groups" width="100%%">
              [html]<thead><tr><td>Respiratory ID. 1 Chronic Obstriction</td><td></td><td>assessed through inspiratory resistive loading. J Bras Pneumol. 2015 ; 41 ( 2 ): 143 - 150.</td></tr></thead><tbody><tr><td>• Asthma. Global management and mitiative for Asthma aly 30.2023. https :// ontem / uploads / 2023 /- report - 23_07_06 -</td><td>25.</td><td>Ekstrim M. Bornefalk H. Skidd M, et al. Validation of the Swedish Multidimensional Drogmea Profile ( MDP ) in outpatients with cardiorespiratory disease. F04T Upen Respor Res. 2019 / 8 : e0038.</td></tr><tr><tdrowspan="2">Chronic Obstructive Althractive Benefits of pulmonary disease, Chronic Obstructive te, Accessed July 30.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10,</td><td>26.</td><td>Yorke [, Russell AM, Swigris [, et al. Assessment of dyspnea in asthma validation of The 199661 - 12.7 Antherococcus of The 199661 - 12.7 Antherococcus of Active Bordet UP, Borday ME, Cote A, et al. Aurway initiationalized and hypertensive</td></tr><tr><td>27.</td><td>Bodet 1. P. Boday ME, Cote A, et al. Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry. Else Region?. 202361 ( 3 ): 2201194.</td></tr><tr><td>San M, Whitmore GA,’ preserved ratio ( PRI5m ) wing pre lator spirometry in a symptomatic cohort. E. Med. 2023 ; 208 ( 10 ):</td><td>28.</td><td>Genterin E, Biorbrier J, Whitmon GA, et al. Impact of undiagnosed chronic obstructive pulmonary disease and asthma on symptoms, quality of life, healthcare use, and work productivity. Am J Regipr Crit Care Mod. 2023 ; 200012 ): 1271 - 1282</td></tr><tr><tdrowspan="2">Antional DE. Activity - chronic obstructive : physical and equences, unimet directions. Inf J amon</td><td>29.</td><td>Aarve 5D, Vardembeen K, Whitmore GA, et al. Early diagnosis and treatment of COPD and asthma : a randomized, controlled trial. N Engl / Med. 2024.390 ( 22 ): 2061 - 2073.</td></tr><tr><td>30.</td><td>Han MK, Ye Wang D, et al. Bronchodilators in tobacco - exposed persons with symptoms and preserved lung function. N Engl1 Med. 2022.387 ( 13 ); 1173 - 1184.</td></tr><tr><td>D, et al. DatabasesD, et al. Bation and theirn airway symptoms flow in allergicn season – a paneland Southern Sweden.</td><td>31.</td><td>Marott II, Ingelvigisen T5, Colak Y, et al. Impact of the metabolic syndrome on cardiopulmonary morbidity and mortality in individuals with lung function impairment. a prospective cohort stady of the Damisb general propulation. Lence</td></tr><tr><tdrowspan="2">32.</td><td>Stefan MS, Priya A, Martin B, et al. How well do patients and providers agree on the severity of dyspnea? J Hosp Mol. 2016 ; 11 ( 10 ): 701 - 707.</td><td>33.</td></tr><tr><td>Cherias M, Magner KMA, Whitnore GA, et al. Patient and physician factors associated with symptomatic undiagnosed asthma or COPD. Esr Respir J. 202361 ( 2 ): 2201721.</td></tr></tbody>
          </table> </body> </html>